gms | German Medical Science

MAINZ//2011: 56. GMDS-Jahrestagung und 6. DGEpi-Jahrestagung

Deutsche Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie e. V.
Deutsche Gesellschaft für Epidemiologie e. V.

26. - 29.09.2011 in Mainz

Long-term prognosis of cancer patients in Germany:Up-to-date national estimates, regional variation and international comparisons

Meeting Abstract

Suche in Medline nach

  • Hermann Brenner - Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg
  • Alexander Katalinic - Institute for Cancer Epidemiology e.V., University, Lübeck

Mainz//2011. 56. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie (gmds), 6. Jahrestagung der Deutschen Gesellschaft für Epidemiologie (DGEpi). Mainz, 26.-29.09.2011. Düsseldorf: German Medical Science GMS Publishing House; 2011. Doc11gmds608

doi: 10.3205/11gmds608, urn:nbn:de:0183-11gmds6081

Veröffentlicht: 20. September 2011

© 2011 Brenner et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen ( Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.



Background: Monitoring cancer survival by population-based cancer registries is a prerequisite for evaluating overall quality of cancer care. In the past, population-based cancer survival data from Germany were often restricted to Saarland (about 1 of >80 million inhabitants).

Methods: We set up a workgroup of all population-based cancer registries in Germany with reasonably complete registration of cancer cases and mortality follow-up in 1997-2006. Population-based cancer registries from 11 of 16 federal states covering a population of 33 million people were included. The database currently includes more than 1.3 million patients diagnosed with cancer and followed with respect to vital status in 1997-2006. Main analyses consist of period analysis of 5-year relative survival in 2002-2006, as well as modelled period analysis on trends in relative survival during this recent period.

First results: Initial overview analyses yielded 5-year relative survival estimates that for most cancers are higher than the pan-European estimates from international collaborative studies, such as the EUROCARE-4 study, and close to or slightly below corresponding survival estimates from the US [1]. Furthermore, within two decades after the fall of the iron curtain, cancer survival rates in the Eastern and Western states of Germany have come very close.

Outlook: Currently, in-depth analyses are conducted on relative survival by age, sex, subsite and morphology for specific forms of cancer. In addition, in-depth analyses are carried out on variation of cancer survival by county level socioeconomic characteristics. Members of the workgroup from all participating cancer registries are actively involved in these analyses.


Hiripi E, Gondos A, Emrich K, Holleczek B, Katalinic A, Luttmann S, Sirri E, Brenner H, GEKID Cancer Survival Working Group. Survival from common and rare cancers in Germany in the early 21st century. Ann Oncol. 2011. DOI: 10.1093/annonc/mdr131 Externer Link